Business
Novocure Announces 15 Presentations at the American Society for Radiation Oncology 2021 Annual Meeting
Highlights include presentations by external authors studying the effects of concurrent Tumor Treating Fields and chemoradiation for patients with newly
About this update from Novocure Limited
[{"type":"text","content":"\nHighlights include presentations by external authors studying the effects of concurrent Tumor Treating Fields and chemoradiation for patients with newly diagnosed glioblastoma\n\n ST. HELIER, Jersey--(BUSINESS WIRE)--\nNovocure (NASDAQ: NVCR) today announced 15 presentations on Tumor Treating Fields (TTFields) will be featured at the American Society for Radiation Oncology (ASTRO) 2021 Annual Meeting from Oct. 24 to Oct. 27 in Chicago. External authors prepared five of the presentations, three of which include new data, reflecting continued interest in Novocure’s proprietary TTFields platform within the radiation oncology community.\n\nTwo presentations will feature new data on the investigational use of concurrent TTFields and chemoradiation for patients with newly diagnosed glioblastoma (GBM). Another presentation will highlight new data on the effects of TTFields in combination with irradiation on human GBM cells.\n\n“We and our partners are excited to present and see a variety of research on Tumor Treating Fields at ASTRO’s 2021 Annual Meeting,” said Dr. Ely Benaim, Novocure’s Chief Medical Officer. “We appreciate the opportunity to continue our partnership with the radiation oncology community in working to establish Tumor Treating Fields as an important treatment for solid tumors. We look forward to participating in the exchange of scientific information at one of the premier meetings for radiation oncologists.”\n\nThe following will be presented at the ASTRO 2021 Annual Meeting:\n\nPoster Presentations\n\n(2045) Mechanism of action of Tumor Treating Fields (TTFields) in combination with sorafenib for treatment of hepatocellular carcinoma. Lead author: S. Davidi. Presenter: E. Dor-On. 1:30 p.m. to 2:45 p.m. CDT Sunday, Oct. 24.\n\n(2250) Comprehensive approaches to enhancing Tumor Treating Fields dose at the tumor. Lead author and presenter: Z. Bomzon. 4:45 p.m. to 6 p.m. CDT Sunday, Oct. 24.\n\n(2251) Framework for dosimetry and treatment planning of TTFields. Lead author and presenter: Z. Bomzon. 4:45 p.m. to 6 p.m. CDT Sunday, Oct. 24.\n\n(2252) Tumor Treating Fields (TTFields) treatment planning for a patient with astrocytoma in the spinal cord. Lead author and presenter: J. De Los Santos. 4:45 p.m. to 6 p.m. CDT Sunday, Oct. 24.\n\n(2253) Creating computational models for planning TTFields treatment for tumors in th...